BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2014
View Archived Issues
Sanofi reports progress across key programs in fourth quarter 2013
Read More
Revive Therapeutics reports interim data from phase IIa study of REV-001
Read More
Canadian researchers patent new immunoglobulin constructs
Read More
New vaccine company Abivax created
Read More
Pierre Fabre obtains worldwide rights to immune checkpoint modulator from Aurigene
Read More
Development of a dual serotonin receptor antagonist for the treatment of patients with dementia
Read More
FDA grants full approval to Synribo for injection
Read More
X-Chem licenses epigenetic program to Bayer Pharma
Read More
Aerpio Therapeutics begins phase II study of AKB-9778 in diabetic macular edema
Read More
Merck & Co. presents new ROMK blockers
Read More
Sphaera Pharma designs new signal transduction inhibitors for cancer
Read More
Bristol-Myers Squibb prepares novel P2Y1 receptor antagonists for thrombosis
Read More
Agenus aims to develop cancer immunotherapy program with acquisition of 4-Antibody
Read More
Bionomics prepares new nicotinic acetylcholine receptor modulators
Read More
Scientists at Bristol-Myers Squibb patent new AAK1 inhibitors for pain and other disorders
Read More
Preliminary phase II results presented for pazopanib/paclitaxel combination in urothelial carcinoma
Read More
Decreased GATA1 mRNA expression associated with poor clinical prognosis in ccRCC
Read More
Lilly describes nonsteroidal glucocorticoid antagonist that minimizes treatment-related weight gain
Read More
Otsuka Pharmaceutical recaps highlights of third quarter of fiscal 2013
Read More
Isis Pharmaceuticals provides update on trials of ISIS-SMNRx in spinal muscular atrophy
Read More
Ampio reports preliminary findings from biochemical analysis from SPRING study
Read More
Alexion, Prothelia and University of Nevada enter agreements for laminin-111
Read More
SwissMedic approves Actelion's Opsumit for pulmonary arterial hypertension
Read More
AVEO and Astellas to end worldwide tivozanib collaboration
Read More